These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3370278)

  • 21. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone.
    Reincke M; Allolio B; Würth G; Winkelmann W
    J Clin Endocrinol Metab; 1993 Jul; 77(1):151-6. PubMed ID: 8392081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dexamethasone suppression test and plasma dexamethasone levels in bulimia.
    Walsh BT; Lo ES; Cooper T; Lindy DC; Roose SP; Gladis M; Glassman AH
    Arch Gen Psychiatry; 1987 Sep; 44(9):797-800. PubMed ID: 3632253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The lower limits of dexamethasone window in Chinese depressives.
    Shiah IS; Ko HC; Lu RB
    Biol Psychiatry; 1998 Oct; 44(7):648-55. PubMed ID: 9787892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroendocrine effects of ovine corticotropin-releasing hormone in panic disorder patients.
    Rapaport MH; Risch SC; Golshan S; Gillin JC
    Biol Psychiatry; 1989 Aug; 26(4):344-8. PubMed ID: 2548630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reproducibility of the low dose dexamethasone suppression test: comparison between direct plasma and salivary cortisol assays.
    Reynolds RM; Bendall HE; Whorwood CB; Wood PJ; Walker BR; Phillips DI
    Clin Endocrinol (Oxf); 1998 Sep; 49(3):307-10. PubMed ID: 9861320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paper chromatography prior to cortisol RIA allows for accurate use of the dexamethasone suppression test in chronic renal failure.
    Van Herle AJ; Birnbaum JA; Slomowitz LA; Mayes D; Chandler DW; Rosenblit PD; Nissenson A
    Nephron; 1998 Sep; 80(1):79-84. PubMed ID: 9730710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of hospital admission on DST results in patients with panic disorder.
    Szádóczky E; Rihmer Z; Arató M
    Am J Psychiatry; 1986 Oct; 143(10):1315-6. PubMed ID: 3766800
    [No Abstract]   [Full Text] [Related]  

  • 28. Pituitary adrenocortical unresponsiveness in lactate-induced panic.
    Levin AP; Doran AR; Liebowitz MR; Fyer AJ; Gorman JM; Klein DF; Paul SM
    Psychiatry Res; 1987 May; 21(1):23-32. PubMed ID: 3037579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of the DST results in depressives by means of urinary-free cortisol excretion, dexamethasone levels, and age.
    Maes M; Jacobs MP; Suy E; Minner B; Raus J
    Biol Psychiatry; 1990 Aug; 28(4):349-57. PubMed ID: 2397250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The plasma dexamethasone window: evidence supporting its usefulness to validate dexamethasone suppression test results.
    O'Sullivan BT; Hunt GE; Johnson GF; Caterson ID
    Biol Psychiatry; 1989 Mar; 25(6):739-54. PubMed ID: 2923936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationships between psychological distress, coping styles, and HPA axis reactivity in healthy adults.
    Hori H; Ozeki Y; Teraishi T; Matsuo J; Kawamoto Y; Kinoshita Y; Suto S; Terada S; Higuchi T; Kunugi H
    J Psychiatr Res; 2010 Oct; 44(14):865-73. PubMed ID: 20334880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma dexamethasone levels in children given the dexamethasone suppression test.
    Naylor MW; Greden JF; Alessi NE
    Biol Psychiatry; 1990 Mar; 27(6):592-600. PubMed ID: 2322618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The dexamethasone suppression test in inpatients with panic disorder or agoraphobia with panic attacks.
    Grunhaus L; Tiongco D; Haskett RF; Greden JF
    Biol Psychiatry; 1987 Apr; 22(4):517-21. PubMed ID: 3567265
    [No Abstract]   [Full Text] [Related]  

  • 34. Dexamethasone suppression test in patients with panic disorder and secondary depression.
    Bueno JA; Sabanes F; Gascon J; Gasto C; Salamero M
    Arch Gen Psychiatry; 1984 Jul; 41(7):723-4. PubMed ID: 6732433
    [No Abstract]   [Full Text] [Related]  

  • 35. The dexamethasone suppression test in panic disorder and agoraphobia.
    Curtis GC; Cameron OG; Nesse RM
    Am J Psychiatry; 1982 Aug; 139(8):1043-6. PubMed ID: 7091428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of solid-phase radioimmunoassay and competitive protein binding method for postdexamethasone cortisol levels in psychiatric patients.
    Wilens TE; Arana GW; Baldessarini RJ; Cremens C
    Psychiatry Res; 1983 Mar; 8(3):199-206. PubMed ID: 6574539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salivary cortisol levels in persons with and without different anxiety disorders.
    Vreeburg SA; Zitman FG; van Pelt J; Derijk RH; Verhagen JC; van Dyck R; Hoogendijk WJ; Smit JH; Penninx BW
    Psychosom Med; 2010 May; 72(4):340-7. PubMed ID: 20190128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fenfluramine, cortisol, and anxiety.
    Hollander E; Liebowitz MR; DeCaria C; Klein DF
    Psychiatry Res; 1990 Feb; 31(2):211-3. PubMed ID: 2360951
    [No Abstract]   [Full Text] [Related]  

  • 39. Postdexamethasone plasma cortisol and beta-endorphin levels in depression: relationship to severity of illness.
    Meador-Woodruff JH; Haskett RF; Grunhaus L; Akil H; Watson SJ; Greden JF
    Biol Psychiatry; 1987 Sep; 22(9):1137-50. PubMed ID: 2958096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypothalamic-pituitary-adrenal axis in corticosteroid-resistant bronchial asthma.
    Lane SJ; Atkinson BA; Swaminathan R; Lee TH
    Am J Respir Crit Care Med; 1996 Feb; 153(2):557-60. PubMed ID: 8564097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.